A detailed history of Birchbrook, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Birchbrook, Inc. holds 17,057 shares of BMY stock, worth $759,718. This represents 0.42% of its overall portfolio holdings.

Number of Shares
17,057
Previous 17,009 0.28%
Holding current value
$759,718
Previous $1.04 Billion 23.89%
% of portfolio
0.42%
Previous 0.58%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

BUY
$44.12 - $59.6 $2,117 - $2,860
48 Added 0.28%
17,057 $790 Million
Q1 2025

Jun 10, 2025

SELL
$53.9 - $63.11 $41,664 - $48,784
-773 Reduced 4.35%
17,009 $1.04 Billion
Q4 2024

Jun 10, 2025

SELL
$51.92 - $59.94 $115,418 - $133,246
-2,223 Reduced 11.11%
17,782 $1.01 Billion
Q3 2024

Jun 10, 2025

SELL
$39.66 - $51.75 $345,636 - $451,001
-8,715 Reduced 30.34%
20,005 $1.04 Billion
Q2 2024

Jun 10, 2025

BUY
$40.25 - $52.99 $24,794 - $32,641
616 Added 2.19%
28,720 $1.19 Billion
Q1 2024

Jun 10, 2025

BUY
$47.98 - $54.4 $130,457 - $147,913
2,719 Added 10.71%
28,104 $1.52 Billion
Q4 2023

Jun 10, 2025

BUY
$48.48 - $57.85 $1.23 Million - $1.47 Million
25,385 New
25,385 $1.3 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $94.7B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Birchbrook, Inc. Portfolio

Follow Birchbrook, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchbrook, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Birchbrook, Inc. with notifications on news.